Novel combination of metformin & resveratrol alleviates fatty liver by activating auto

Well SupportedDavid Sinclair has been taking resveratrol since 2003 without apparent harm and reports a heart that appears 20 years younger on MRI.

Partially SupportedResveratrol-metformin combination reduced lipid accumulation and lipogenic gene expression in palmitic acid-induced HepG2 liver cells.

Partially SupportedResveratrol-metformin reduces hepatic steatosis by triggering autophagy via the cAMP/AMPK/SIRT1 signaling pathway.

Partially SupportedA combination of metformin and resveratrol alleviates nonalcoholic fatty liver disease (NAFLD) by activating autophagy via the AMPK/SIRT1 signaling pathway.

Partially Supported

Novel combination of metformin &amp; resveratrol alleviates fatty liver by activating auto

Novel combination of metformin & resveratrol alleviates fatty liver by activating auto